According to a new report, published by KBV research, The Global Intracranial Aneurysm Market size is expected to reach $2.1 billion by 2030, rising at a market growth of 8.5% CAGR during the forecast period.
The market refers to the collective ecosystem of products, services, and stakeholders involved in diagnosing, treating, and managing these aneurysms. This market encompasses various medical specialties, including neurology, neurosurgery, interventional radiology, vascular medicine, pharmaceutical companies, medical device manufacturers, healthcare providers, and research institutions.
The future of the market holds promise driven by advancements in diagnostic technologies, minimally invasive treatment modalities, and multidisciplinary care approaches. With increasing awareness, screening programs, and genetic testing capabilities, more cases of these aneurysms are expected to be detected early, enabling timely interventions to prevent ruptures and associated complications. Innovations in endovascular techniques, including flow diverters, intravascular devices, and embolic agents, are revolutionizing treatment options, offering safer and more effective alternatives to traditional surgical approaches. Additionally, integrating artificial intelligence, robotics, and image-guided navigation systems enhances procedural precision, outcomes, and patient safety.
The Hospitals segment led the Global Intracranial Aneurysm Market by End-use in 2022; thereby, achieving a market value of $1.3 Billion by 2030. The increasing demand in the hospitals segment can be ascribed to the hospitals' provision of collaborative research and academic excellence, specialized infrastructure, comprehensive care services, access to specialized expertise, advanced technologies, and equipment, and round-the-clock emergency care. Additionally, improved access to healthcare services, especially in developing countries, can lead to more cases being diagnosed and treated, increasing demand for aneurysm treatments in hospitals.
The Endovascular Coiling segment is growing at a CAGR of 8 % during the forecast period. Through endovascular coiling, a catheter is guided through the blood vessels to the site of the cerebral aneurysm as part of a minimally invasive procedure. Furthermore, endovascular coiling requires smaller incisions, reduces the risk of complications, and typically results in shorter hospital stays and faster recovery times. As patients and clinicians increasingly prioritize less invasive treatment options, the demand for endovascular coiling continues to rise.
Full Report: https://www.kbvresearch.com/intracranial-aneurysm-market/
The North America region dominated the Global Intracranial Aneurysm Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $713.6 Million by 2030. The Europe region is anticipated to grow at a CAGR of 8.3% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 9.3% during (2023 - 2030).
By End-use
By Type
By Geography
Unique Offerings 
